Fleet Lawsuit: Kidney Failure (Acute Phosphate Nephropathy)

Pritzker | Ruohonen, a nationally-recognized product liability law firm, is representing a number of clients who have suffered renal failure (kidney failure) after the use of certain Fleet products. If you are interested in a Visicol or Fleet lawsuit, please fill out our Visicol and Fleet lawsuit Questionnaire. For additional Fleet lawsuit information, contact Pritzker | Ruohonen toll free at 1-888-377-8900 or fill out the firm's online-consultation form.

Below is the FDA health alert regarding the Fleet products.

May 5, 2006 – The Food and Drug Administration (FDA) is warning health care professionals and patients that a rare but serious form of kidney failure (acute phosphate nephropathy) has been associated with the use of oral sodium phosphate (OSP) products (e.g., Fleet Phospho-soda solution, Fleet Accu-Prep solution, and Visicol tablets) for bowel cleansing. OSP products are commonly used for bowel cleansing prior to colonoscopy, radiographic procedures, and surgery. Documented cases of acute phosphate nephropathy include 21 patients who used an OSP solution (such as Fleet Phospho-soda and Fleet ACCU-PREP) and one patient who used OSP tablets (Visicol).

The following is a summary from the FDA:

Acute phosphate nephropathy, a type of acute renal failure, is a rare, but serious adverse event associated with oral sodium phosphate bowel cleansing.
When acute phosphate nephropathy occurs, renal impairment is often permanent and may require chronic dialysis.
Individuals at increased risk include: those of advanced age, those with decreased intravascular volume or kidney disease, and those using medicines that affect renal perfusion or function [diuretics, angiotensin converting enzyme (ACE) inhibitors, angiotensin receptor blockers (ARBs), and possibly nonsteroidal anti-inflammatory drugs (NSAIDs)].

OSP Products (Fleet and Visicol) and Kidney Failure: Lawyer and Free Consultation
If you have had a colonoscopy, radiological procedure, or surgery and have developed kidney failure, a lawyer at Pritzker | Ruohonen, a nationally-recognized law firm, is available for a free consultation. You may reach us toll-free at 1-888-377-8900 or fill in our online consultation form. Senior partner Fred Pritzker has over 29 years of experience and focuses his practice on complex product liability cases. In recognition of his achievements, other lawyers have selected him for inclusion in the 2005-2006 edition of The Best Lawyers in America. He has written online information on defective medical product lawsuits.

Source: Food and Drug Administration Science Background Paper (http://www.fda.gov/)

Free Case Consultation

Unsafe Medical Featured Topics

Deaths Prompt Warnings for Haldol

The WARNINGS section of the prescribing information for Haldol (haloperidol, an antipsychotic medication), a Johnson & Johnson product, has been revised to include a new cardiovascular (heart-related) subsection regarding cases of sudden death, QT prolongation and torsades de pointes(TdP) in patients treated with haloperidol, especially when given intravenously, or at doses higher than recommended. Read more about haloperidol and a Haldol (haloperidol) lawsuit.

Deaths of Patients Treated with FENTORA

There have been serious, adverse events, including deaths in patients treated with FENTORA (fentanyl buccal tablet). According to the manufacturer of FENTORA, Cephalon, “These deaths occurred as a result of improper patient selection (e.g., use in opioid non-tolerant patients), improper dosing, and/or improper product substitution.” Read FENTORA lawsuit and lawyer information.

New Boxed Warning for Xolair

Anaphylaxis (severe allergic reaction) has occurred in some patients who were administered Xolair, an asthma medication manufactured by Genentech, Inc. 15% of the reported cases required hospitalization. Learn more about the Xolair boxed warning.

Ceftin, Fortaz, Rocephin, and Zinacef

Ceftin, Fortaz, Rocephin, and Zinacef (cephalosporin-based antibiotic medications) can cause pseudomembranous colitis, severe inflammation in areas of the colon (large intestine). Children are particularly susceptible to developing antibiotic-related colitis, which can cause serious illness and death. Read about the new label precautions and warnings for Ceftin, Fortaz, Rocephin, and Zinacef.

Continued Risks of Duragesic and Fentanyl

In July of 2005, the FDA issued an advisory regarding reports of death and other serious side effects from overdoses of fentanyl in patients using fentanyl transdermal (skin) patches for pain control. Deaths and overdoses had occurred in patients using both the brand name product Duragesic and the generic product (at the time there was only one generic product).

Complete Moisture Plus Recall

The FDA has announced that many consumers may not be aware of the May 2007 recall of Complete MoisturePlus Multipurpose Contact Lens Solution manufactured by Advanced Medical Optics (AMO). Learn more about the recall and a Complete Moisture Plus lawsuit.

Infant Deaths May Be Linked to Rocephin

Rocephin (ceftriaxone sodium) may be linked to the deaths of newborn infants. The babies most at risk are premature infants who are hyperbilirubinemic (a condition associated with jaundice). Learn more about Rocephin and the risk of death or injury.

Colistimethate May Have Caused Death

The FDA has received a report about the death of a patient with cystic fibrosis (CF) who used the antibiotic Colistimethate that had been premixed by a pharmacy into a liquid for inhalation with a nebulizer. Learn more about Colistimethate.